• レポートコード:QYR2104Z2546 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、93ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、ゲノミクスバイオマーカーのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(腫瘍、循環器疾患、神経疾患)、用途別市場規模(診断・研究所、病院)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・ゲノミクスバイオマーカーの市場動向 ・企業の競争状況、市場シェア ・ゲノミクスバイオマーカーの種類別市場規模(腫瘍、循環器疾患、神経疾患) ・ゲノミクスバイオマーカーの用途別市場規模(診断・研究所、病院) ・ゲノミクスバイオマーカーの北米市場規模2016-2027(アメリカ、カナダ) ・ゲノミクスバイオマーカーのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・ゲノミクスバイオマーカーのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・ゲノミクスバイオマーカーの中南米市場規模2016-2027(メキシコ、ブラジル) ・ゲノミクスバイオマーカーの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Roche Diagnostics、Myriad Genetics、QIAGEN、Thermo Fisher Scientific、Bio-Rad Laboratories) ・結論 |
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers such as cancer biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.
Market Analysis and Insights: Global Genomics Biomarkers Market
The global Genomics Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genomics Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genomics Biomarkers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genomics Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genomics Biomarkers market.
Global Genomics Biomarkers Scope and Market Size
Genomics Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genomics Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oncology
Cardiovascular Diseases
Neurological Diseases
Segment by Application
Diagnostic and Research Laboratories
Hospitals
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche Diagnostics
Myriad Genetics
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics Biomarkers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oncology
1.2.3 Cardiovascular Diseases
1.2.4 Neurological Diseases
1.3 Market by Application
1.3.1 Global Genomics Biomarkers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic and Research Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genomics Biomarkers Market Perspective (2016-2027)
2.2 Genomics Biomarkers Growth Trends by Regions
2.2.1 Genomics Biomarkers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Genomics Biomarkers Historic Market Share by Regions (2016-2021)
2.2.3 Genomics Biomarkers Forecasted Market Size by Regions (2022-2027)
2.3 Genomics Biomarkers Industry Dynamic
2.3.1 Genomics Biomarkers Market Trends
2.3.2 Genomics Biomarkers Market Drivers
2.3.3 Genomics Biomarkers Market Challenges
2.3.4 Genomics Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomics Biomarkers Players by Revenue
3.1.1 Global Top Genomics Biomarkers Players by Revenue (2016-2021)
3.1.2 Global Genomics Biomarkers Revenue Market Share by Players (2016-2021)
3.2 Global Genomics Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Genomics Biomarkers Revenue
3.4 Global Genomics Biomarkers Market Concentration Ratio
3.4.1 Global Genomics Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics Biomarkers Revenue in 2020
3.5 Genomics Biomarkers Key Players Head office and Area Served
3.6 Key Players Genomics Biomarkers Product Solution and Service
3.7 Date of Enter into Genomics Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics Biomarkers Breakdown Data by Type
4.1 Global Genomics Biomarkers Historic Market Size by Type (2016-2021)
4.2 Global Genomics Biomarkers Forecasted Market Size by Type (2022-2027)
5 Genomics Biomarkers Breakdown Data by Application
5.1 Global Genomics Biomarkers Historic Market Size by Application (2016-2021)
5.2 Global Genomics Biomarkers Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Genomics Biomarkers Market Size (2016-2027)
6.2 North America Genomics Biomarkers Market Size by Type
6.2.1 North America Genomics Biomarkers Market Size by Type (2016-2021)
6.2.2 North America Genomics Biomarkers Market Size by Type (2022-2027)
6.2.3 North America Genomics Biomarkers Market Size by Type (2016-2027)
6.3 North America Genomics Biomarkers Market Size by Application
6.3.1 North America Genomics Biomarkers Market Size by Application (2016-2021)
6.3.2 North America Genomics Biomarkers Market Size by Application (2022-2027)
6.3.3 North America Genomics Biomarkers Market Size by Application (2016-2027)
6.4 North America Genomics Biomarkers Market Size by Country
6.4.1 North America Genomics Biomarkers Market Size by Country (2016-2021)
6.4.2 North America Genomics Biomarkers Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Genomics Biomarkers Market Size (2016-2027)
7.2 Europe Genomics Biomarkers Market Size by Type
7.2.1 Europe Genomics Biomarkers Market Size by Type (2016-2021)
7.2.2 Europe Genomics Biomarkers Market Size by Type (2022-2027)
7.2.3 Europe Genomics Biomarkers Market Size by Type (2016-2027)
7.3 Europe Genomics Biomarkers Market Size by Application
7.3.1 Europe Genomics Biomarkers Market Size by Application (2016-2021)
7.3.2 Europe Genomics Biomarkers Market Size by Application (2022-2027)
7.3.3 Europe Genomics Biomarkers Market Size by Application (2016-2027)
7.4 Europe Genomics Biomarkers Market Size by Country
7.4.1 Europe Genomics Biomarkers Market Size by Country (2016-2021)
7.4.2 Europe Genomics Biomarkers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Genomics Biomarkers Market Size (2016-2027)
8.2 Asia-Pacific Genomics Biomarkers Market Size by Type
8.2.1 Asia-Pacific Genomics Biomarkers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Genomics Biomarkers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Genomics Biomarkers Market Size by Type (2016-2027)
8.3 Asia-Pacific Genomics Biomarkers Market Size by Application
8.3.1 Asia-Pacific Genomics Biomarkers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Genomics Biomarkers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Genomics Biomarkers Market Size by Application (2016-2027)
8.4 Asia-Pacific Genomics Biomarkers Market Size by Region
8.4.1 Asia-Pacific Genomics Biomarkers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Genomics Biomarkers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Genomics Biomarkers Market Size (2016-2027)
9.2 Latin America Genomics Biomarkers Market Size by Type
9.2.1 Latin America Genomics Biomarkers Market Size by Type (2016-2021)
9.2.2 Latin America Genomics Biomarkers Market Size by Type (2022-2027)
9.2.3 Latin America Genomics Biomarkers Market Size by Type (2016-2027)
9.3 Latin America Genomics Biomarkers Market Size by Application
9.3.1 Latin America Genomics Biomarkers Market Size by Application (2016-2021)
9.3.2 Latin America Genomics Biomarkers Market Size by Application (2022-2027)
9.3.3 Latin America Genomics Biomarkers Market Size by Application (2016-2027)
9.4 Latin America Genomics Biomarkers Market Size by Country
9.4.1 Latin America Genomics Biomarkers Market Size by Country (2016-2021)
9.4.2 Latin America Genomics Biomarkers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomics Biomarkers Market Size (2016-2027)
10.2 Middle East & Africa Genomics Biomarkers Market Size by Type
10.2.1 Middle East & Africa Genomics Biomarkers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Genomics Biomarkers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Genomics Biomarkers Market Size by Type (2016-2027)
10.3 Middle East & Africa Genomics Biomarkers Market Size by Application
10.3.1 Middle East & Africa Genomics Biomarkers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Genomics Biomarkers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Genomics Biomarkers Market Size by Application (2016-2027)
10.4 Middle East & Africa Genomics Biomarkers Market Size by Country
10.4.1 Middle East & Africa Genomics Biomarkers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Genomics Biomarkers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Genomics Biomarkers Introduction
11.1.4 Roche Diagnostics Revenue in Genomics Biomarkers Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 Myriad Genetics
11.2.1 Myriad Genetics Company Details
11.2.2 Myriad Genetics Business Overview
11.2.3 Myriad Genetics Genomics Biomarkers Introduction
11.2.4 Myriad Genetics Revenue in Genomics Biomarkers Business (2016-2021)
11.2.5 Myriad Genetics Recent Development
11.3 QIAGEN
11.3.1 QIAGEN Company Details
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN Genomics Biomarkers Introduction
11.3.4 QIAGEN Revenue in Genomics Biomarkers Business (2016-2021)
11.3.5 QIAGEN Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Genomics Biomarkers Introduction
11.4.4 Thermo Fisher Scientific Revenue in Genomics Biomarkers Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Genomics Biomarkers Introduction
11.5.4 Bio-Rad Laboratories Revenue in Genomics Biomarkers Business (2016-2021)
11.5.5 Bio-Rad Laboratories Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Genomics Biomarkers Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oncology
Table 3. Key Players of Cardiovascular Diseases
Table 4. Key Players of Neurological Diseases
Table 5. Global Genomics Biomarkers Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Genomics Biomarkers Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Genomics Biomarkers Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Genomics Biomarkers Market Share by Regions (2016-2021)
Table 9. Global Genomics Biomarkers Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Genomics Biomarkers Market Share by Regions (2022-2027)
Table 11. Genomics Biomarkers Market Trends
Table 12. Genomics Biomarkers Market Drivers
Table 13. Genomics Biomarkers Market Challenges
Table 14. Genomics Biomarkers Market Restraints
Table 15. Global Genomics Biomarkers Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Genomics Biomarkers Market Share by Players (2016-2021)
Table 17. Global Top Genomics Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics Biomarkers as of 2020)
Table 18. Ranking of Global Top Genomics Biomarkers Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Genomics Biomarkers Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Genomics Biomarkers Product Solution and Service
Table 22. Date of Enter into Genomics Biomarkers Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genomics Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Genomics Biomarkers Revenue Market Share by Type (2016-2021)
Table 26. Global Genomics Biomarkers Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Genomics Biomarkers Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Genomics Biomarkers Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Genomics Biomarkers Revenue Market Share by Application (2016-2021)
Table 30. Global Genomics Biomarkers Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Genomics Biomarkers Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Genomics Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Genomics Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Genomics Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Genomics Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Genomics Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Genomics Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Genomics Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Genomics Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Genomics Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Genomics Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Genomics Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Genomics Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Genomics Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Genomics Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Genomics Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Genomics Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Genomics Biomarkers Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Genomics Biomarkers Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Genomics Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Genomics Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Genomics Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Genomics Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Genomics Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Genomics Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Genomics Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Genomics Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Genomics Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Genomics Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Genomics Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Genomics Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Diagnostics Company Details
Table 63. Roche Diagnostics Business Overview
Table 64. Roche Diagnostics Genomics Biomarkers Product
Table 65. Roche Diagnostics Revenue in Genomics Biomarkers Business (2016-2021) & (US$ Million)
Table 66. Roche Diagnostics Recent Development
Table 67. Myriad Genetics Company Details
Table 68. Myriad Genetics Business Overview
Table 69. Myriad Genetics Genomics Biomarkers Product
Table 70. Myriad Genetics Revenue in Genomics Biomarkers Business (2016-2021) & (US$ Million)
Table 71. Myriad Genetics Recent Development
Table 72. QIAGEN Company Details
Table 73. QIAGEN Business Overview
Table 74. QIAGEN Genomics Biomarkers Product
Table 75. QIAGEN Revenue in Genomics Biomarkers Business (2016-2021) & (US$ Million)
Table 76. QIAGEN Recent Development
Table 77. Thermo Fisher Scientific Company Details
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Genomics Biomarkers Product
Table 80. Thermo Fisher Scientific Revenue in Genomics Biomarkers Business (2016-2021) & (US$ Million)
Table 81. Thermo Fisher Scientific Recent Development
Table 82. Bio-Rad Laboratories Company Details
Table 83. Bio-Rad Laboratories Business Overview
Table 84. Bio-Rad Laboratories Genomics Biomarkers Product
Table 85. Bio-Rad Laboratories Revenue in Genomics Biomarkers Business (2016-2021) & (US$ Million)
Table 86. Bio-Rad Laboratories Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics Biomarkers Market Share by Type: 2020 VS 2027
Figure 2. Oncology Features
Figure 3. Cardiovascular Diseases Features
Figure 4. Neurological Diseases Features
Figure 5. Global Genomics Biomarkers Market Share by Application: 2020 VS 2027
Figure 6. Diagnostic and Research Laboratories Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Genomics Biomarkers Report Years Considered
Figure 9. Global Genomics Biomarkers Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Genomics Biomarkers Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Genomics Biomarkers Market Share by Regions: 2020 VS 2027
Figure 12. Global Genomics Biomarkers Market Share by Regions (2022-2027)
Figure 13. Global Genomics Biomarkers Market Share by Players in 2020
Figure 14. Global Top Genomics Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics Biomarkers as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Genomics Biomarkers Revenue in 2020
Figure 16. Global Genomics Biomarkers Revenue Market Share by Type (2016-2021)
Figure 17. Global Genomics Biomarkers Revenue Market Share by Type (2022-2027)
Figure 18. North America Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Genomics Biomarkers Market Share by Type (2016-2027)
Figure 20. North America Genomics Biomarkers Market Share by Application (2016-2027)
Figure 21. North America Genomics Biomarkers Market Share by Country (2016-2027)
Figure 22. United States Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Genomics Biomarkers Market Share by Type (2016-2027)
Figure 26. Europe Genomics Biomarkers Market Share by Application (2016-2027)
Figure 27. Europe Genomics Biomarkers Market Share by Country (2016-2027)
Figure 28. Germany Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Genomics Biomarkers Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Genomics Biomarkers Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Genomics Biomarkers Market Share by Region (2016-2027)
Figure 38. China Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Genomics Biomarkers Market Share by Type (2016-2027)
Figure 46. Latin America Genomics Biomarkers Market Share by Application (2016-2027)
Figure 47. Latin America Genomics Biomarkers Market Share by Country (2016-2027)
Figure 48. Mexico Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Genomics Biomarkers Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Genomics Biomarkers Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Genomics Biomarkers Market Share by Country (2016-2027)
Figure 54. Turkey Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Genomics Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Roche Diagnostics Revenue Growth Rate in Genomics Biomarkers Business (2016-2021)
Figure 58. Myriad Genetics Revenue Growth Rate in Genomics Biomarkers Business (2016-2021)
Figure 59. QIAGEN Revenue Growth Rate in Genomics Biomarkers Business (2016-2021)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Genomics Biomarkers Business (2016-2021)
Figure 61. Bio-Rad Laboratories Revenue Growth Rate in Genomics Biomarkers Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed